For more information, please contact: Brian Stansky Senior Director, FastForward Johns Hopkins Technology Ventures 1812 Ashland Avenue – Suite 110, Baltimore, MD 21205 Cell 443-253-2925…
The Journal of the American Medical Association (JAMA) has just published the practice-changing findings of the NIH-funded multinational Kids-DOTT randomized clinical trial. View the Publication…
As of 8/26/2021, when study team members “agree to participate” for any study in eIRB and when a PI submits a new application or further…
NIH Course in Neurotherapeutics Discovery and Development for Academic Scientists March 29-31 2022 Applications are due January 24, 2022 This 4 day short course…
MLK Jr. Community Service Awards Ceremony January 14, 2022 | Noon Register This award recognizes meaningful voluntary community service by faculty, staff and students of…
The Johns Hopkins and Kaiser Permanente Research Collaboration Committee (RCC) is sponsoring joint research applications for 2022. Applications are due by 5pm Eastern Time…
Article courtesy of Emily Myrick/ The HUB Since its inception in 2015, the interdisciplinary project through the Institute for Clinical and Translational Research has prompted…
Article courtesy of Johns Hopkins Technology Ventures Barbara Slusher, Ph.D., M.A.S., director of Johns Hopkins Drug Discovery, and co-leader of the ICTR Drug, Biologics,…
Johns Hopkins University achieves 100% compliance with a federal law designed to reveal clinical trial results. By Patrick Smith The polio vaccine. Penicillin. Anesthesia.…
